Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$228.3M
-7.0% from 2023
Prescriptions
21K
$10,939.46 per claim
Patients
2,053
1,753 prescribers
Total spending, 2024
$228.6M
$111,197.40 per patient
Medicare prescription drug plans paid $228.3M for Prolastin C in 2024, for 20,865 prescriptions and refills to 2,053 patients (down 7.0% from 2023). The average cost per claim was $10,939.46.
Florida had the highest Medicare cost for Prolastin C in 2024: $22.2M for 2,013 claims, followed by Pennsylvania ($13.7M).
Mahmood Alam, pulmonary disease in Whitesburg, KY, had the highest Medicare cost for Prolastin C in 2024: 173 claims costing $2.1M.
Prolastin C is made by Grifols, S.a. (GRFS), listed in the Medicare spending data as Grifols Therape.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Mahmood Alam Whitesburg, KY | Pulmonary Disease | 173 | 18 | $2.1M |
| Naresh P Singh Las Vegas, NV | Pulmonary Disease | 114 | 11 | $1.3M |
| Lohaliz Bobe Port Charlotte, FL |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,702 | 22,304 | 2,054 | $243.9M |
| 2023 | 1,701 | 22,043 | 2,023 | $245.4M |
| 2024 | 1,753 | 20,865 | 2,053 | $228.3M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 113 |
| 11 |
| $1.1M |
| Douglas Hogarth Chicago, IL | Pulmonary Disease | 97 | 11 | $1.0M |
| Dragos G Zanchi Brandon, FL | Pulmonary Disease | 79 | Under 11 | $964K |
| Patrick F Allan Dayton, OH | Critical Care (Intensivists) | 81 | Under 11 | $959K |
| Jing G Wang Columbus, OH | Pulmonary Disease | 68 | Under 11 | $886K |
| Jugroop S Brar Surprise, AZ | Pulmonary Disease | 68 | Under 11 | $883K |
| Christina M Eagan Gainesville, FL | Nurse Practitioner | 70 | 14 | $851K |
| Elias G Issa Blue Ridge, GA | Emergency Medicine | 72 | Under 11 | $823K |
| Elie Mansour La Follette, TN | Internal Medicine | 79 | Under 11 | $810K |
| Daniel T Layish Orlando, FL | Pulmonary Disease | 56 | Under 11 | $743K |
| Ladly Abraham Conway, AR | Pulmonary Disease | 52 | Under 11 | $674K |
| Lori Akers Hazard, KY | Nurse Practitioner | 54 | Under 11 | $659K |
| Mark L Brantly Gainesville, FL | Pulmonary Disease | 48 | Under 11 | $657K |
| Emily K Rehberg Sylacauga, AL | Internal Medicine | 65 | Under 11 | $627K |
| Ramesh Kaul New Castle, PA | Pulmonary Disease | 36 | Under 11 | $618K |
| Patrick S Hume Denver, CO | Critical Care (Intensivists) | 50 | Under 11 | $614K |
| David C Mares Anderson, IN | Pulmonary Disease | 51 | Under 11 | $603K |
| Rafael A Martinez Tampa, FL | Pulmonary Disease | 53 | Under 11 | $565K |
| Brian A Smith Versailles, KY | Family Practice | 37 | Under 11 | $562K |
| Elie M Saab Portsmouth, OH | Pulmonary Disease | 40 | Under 11 | $559K |
| Dileep K Puppala Houston, TX | Pulmonary Disease | 39 | Under 11 | $556K |
| Abul K Azad Schenectady, NY | Pulmonary Disease | 57 | Under 11 | $554K |
| Jay T Heidecker Birmingham, AL | Pulmonary Disease | 48 | Under 11 | $535K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Grifols Therape GRFS | 20,885 | $228.6M |